Cargando…
Favorable response of primary pulmonary lymphoepithelioma-like carcinoma to sintilimab combined with chemotherapy: A case report
BACKGROUND: There is no established treatment for primary pulmonary lymphoepithelioma-like carcinoma (LELC) until now. CASE SUMMARY: In this study, the patient responded well to sintilimab combined with paclitaxel and carboplatin, showing no obvious side effects. Meantime, the values of carbohydrate...
Autores principales: | Zeng, Shu-Ying, Yuan, Jin, Lv, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649564/ https://www.ncbi.nlm.nih.gov/pubmed/36387802 http://dx.doi.org/10.12998/wjcc.v10.i31.11617 |
Ejemplares similares
-
Primary Pulmonary Lymphoepithelioma-Like Carcinoma Response Favorably To Nivolumab: A Case Report
por: Qiu, Zhi-Xin, et al.
Publicado: (2019) -
Primary pulmonary lymphoepithelioma-like carcinoma in Singapore
por: Tay, Chee Kiang, et al.
Publicado: (2018) -
Primary pulmonary lymphoepithelioma-like carcinoma combined with situs inversus totalis
por: Zhu, Tao, et al.
Publicado: (2019) -
Molecular and Clinical Characteristics of Primary Pulmonary Lymphoepithelioma-Like Carcinoma
por: Fan, Ying, et al.
Publicado: (2021) -
Clinical observation of pulmonary lymphoepithelioma-like carcinoma
por: Sha, Zhou, et al.
Publicado: (2021)